Literature DB >> 16239151

How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis.

Peter L Fisher1, Adrian Wells.   

Abstract

Controlled outcome studies investigating the efficacy of psychological treatments for obsessive-compulsive disorder (OCD) have employed different methods of determining the clinical significance of treatment effects. This makes it difficult to draw conclusions regarding the absolute and relative efficacy of psychological treatments for OCD. To address this issue, standardized Jacobson methodology for defining clinically significant change was applied to recent psychological outcome trials for OCD. The proportion of asymptomatic patients following treatment was also calculated. When recovery is defined by Jacobson methodology, exposure and response prevention (ERP) appears the most effective treatment currently available (50-60% recovered). However, when the asymptomatic criterion is used as the index of outcome, ERP and cognitive therapy have low and equivalent recovery rates (approximately 25%).

Entities:  

Mesh:

Year:  2005        PMID: 16239151     DOI: 10.1016/j.brat.2004.11.007

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  31 in total

1.  A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder.

Authors:  Michael P Twohig; Steven C Hayes; Jennifer C Plumb; Larry D Pruitt; Angela B Collins; Holly Hazlett-Stevens; Michelle R Woidneck
Journal:  J Consult Clin Psychol       Date:  2010-10

2.  The Netherlands Obsessive Compulsive Disorder Association (NOCDA) study: design and rationale of a longitudinal naturalistic study of the course of OCD and clinical characteristics of the sample at baseline.

Authors:  Josien Schuurmans; Anton J L M van Balkom; Harold J G M van Megen; Johannes H Smit; Merijn Eikelenboom; Danielle C Cath; Maarten Kaarsemaker; Desiree Oosterbaan; Gert-Jan Hendriks; Koen R J Schruers; Nic J A van der Wee; Gerrit Glas; Patricia van Oppen
Journal:  Int J Methods Psychiatr Res       Date:  2012-11-12       Impact factor: 4.035

3.  OCD is Not a Phobia: An Alternative Conceptualization of OCD.

Authors:  Kieron O'Connor; Jean-Sébastien Audet
Journal:  Clin Neuropsychiatry       Date:  2019-02

4.  Implementation of the Bergen 4-Day Treatment for Obsessive Compulsive Disorder in Iceland.

Authors:  Sóley Dröfn Davíðsdóttir; Ólafía Sigurjónsdóttir; Sigurbjörg Jóna Ludvigsdóttir; Bjarne Hansen; Inger Lill Laukvik; Kristen Hagen; Thröstur Björgvinsson; Gerd Kvale
Journal:  Clin Neuropsychiatry       Date:  2019-02

5.  Forming a Doctor-Patient Alliance During COVID-19 to Enhance Treatment Outcomes for Obsessive-Compulsive Disorder.

Authors:  Dorothy E Stubbe
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-11-05

Review 6.  Letter to the Editor: Recent advances in research on cognition and emotion in OCD: a review.

Authors:  Gideon E Anholt; Eyal Kalanthroff
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

7.  Design and Rationale for a Randomized Controlled Trial Testing the Efficacy of Aerobic Exercise for Patients with Obsessive-Compulsive Disorder.

Authors:  Ana M Abrantes; Nicole McLaughlin; Benjamin D Greenberg; David R Strong; Deborah Riebe; Maria Mancebo; Steven Rasmussen; Julie Desaulniers; Richard A Brown
Journal:  Ment Health Phys Act       Date:  2012-06-30

Review 8.  Advancing psychotherapy and evidence-based psychological interventions.

Authors:  Paul M G Emmelkamp; Daniel David; Tom Beckers; Peter Muris; Pim Cuijpers; Wolfgang Lutz; Gerhard Andersson; Ricardo Araya; Rosa M Banos Rivera; Michael Barkham; Matthias Berking; Thomas Berger; Christina Botella; Per Carlbring; Francesc Colom; Cecilia Essau; Dirk Hermans; Stefan G Hofmann; Susanne Knappe; Thomas H Ollendick; Filip Raes; Winfried Rief; Heleen Riper; Saskia Van Der Oord; Bram Vervliet
Journal:  Int J Methods Psychiatr Res       Date:  2014-01       Impact factor: 4.035

9.  Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Authors:  Kelda H Walsh; Christopher J McDougle
Journal:  Neuropsychiatr Dis Treat       Date:  2011-08-23       Impact factor: 2.570

10.  A promising randomized trial of a new therapy for obsessive-compulsive disorder.

Authors:  Xian-Zhang Hu; You-Sheng Wen; Jian-Dong Ma; Dong-Ming Han; Yu-Xia Li; Shu-Fan Wang
Journal:  Brain Behav       Date:  2012-06-26       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.